Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29201 - 29225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	PDE3A	5139	upregulated	Dasatinib results in increased expression of PDE3A mRNA	12p12.2	A21899
Dasatinib	Approved Investigational	PDGFRB	5159	upregulated	Dasatinib results in increased expression of PDGFRB mRNA	5q32	A21899
Dasatinib	Approved Investigational	PLAU	5328	downregulated	Dasatinib results in decreased expression of PLAU mRNA	10q22.2	A21899
Dasatinib	Approved Investigational	PLEKHH2	130271	upregulated	Dasatinib results in increased expression of PLEKHH2 mRNA	2p21	A21899
Dasatinib	Approved Investigational	PLK1	5347	downregulated	Dasatinib results in decreased expression of PLK1 mRNA	16p12.2	A21899
Dasatinib	Approved Investigational	PLK4	10733	downregulated	Dasatinib results in decreased expression of PLK4 mRNA	4q28.1	A21899
Dasatinib	Approved Investigational	PLN	5350	upregulated	Dasatinib results in increased expression of PLN mRNA	6q22.31	A21899
Dasatinib	Approved Investigational	PLSCR4	57088	upregulated	Dasatinib results in increased expression of PLSCR4 mRNA	3q24	A21899
Dasatinib	Approved Investigational	PLXDC2	84898	upregulated	Dasatinib results in increased expression of PLXDC2 mRNA	10p12.31	A21899
Dasatinib	Approved Investigational	PODN	127435	upregulated	Dasatinib results in increased expression of PODN mRNA	1p32.3	A21899
Dasatinib	Approved Investigational	PODNL1	79883	upregulated	Dasatinib results in increased expression of PODNL1 mRNA	19p13.12	A21899
Dasatinib	Approved Investigational	POLA1	5422	downregulated	Dasatinib results in decreased expression of POLA1 mRNA	Xp22.11-p21.3	A21899
Dasatinib	Approved Investigational	POLA2	23649	downregulated	Dasatinib results in decreased expression of POLA2 mRNA	11q13.1	A21899
Dasatinib	Approved Investigational	POLE2	5427	downregulated	Dasatinib results in decreased expression of POLE2 mRNA	14q21.3	A21899
Dasatinib	Approved Investigational	POLQ	10721	downregulated	Dasatinib results in decreased expression of POLQ mRNA	3q13.33	A21899
Dasatinib	Approved Investigational	POLR3G	10622	downregulated	Dasatinib results in decreased expression of POLR3G mRNA	5q14.3	A21899
Dasatinib	Approved Investigational	PPP1R3C	5507	upregulated	Dasatinib results in increased expression of PPP1R3C mRNA	10q23.32	A21899
Dasatinib	Approved Investigational	PRC1	9055	downregulated	Dasatinib results in decreased expression of PRC1 mRNA	15q26.1	A21899
Dasatinib	Approved Investigational	PRIM1	5557	downregulated	Dasatinib results in decreased expression of PRIM1 mRNA	12q13.3	A21899
Dasatinib	Approved Investigational	PRIM2	5558	downregulated	Dasatinib results in decreased expression of PRIM2 mRNA	6p11.2	A21899
Dasatinib	Approved Investigational	PRR11	55771	downregulated	Dasatinib results in decreased expression of PRR11 mRNA	17q23.2	A21899
Dasatinib	Approved Investigational	PSAT1	29968	upregulated	Dasatinib results in increased expression of PSAT1 mRNA	9q21.2	A21899
Dasatinib	Approved Investigational	PSMC3IP	29893	downregulated	Dasatinib results in decreased expression of PSMC3IP mRNA	17q21.2	A21899
Dasatinib	Approved Investigational	PTGIS	5740	upregulated	Dasatinib results in increased expression of PTGIS mRNA	20q13.13	A21899
Dasatinib	Approved Investigational	PTTG1	9232	downregulated	Dasatinib results in decreased expression of PTTG1 mRNA	5q33.3	A21899

Displaying entries 29201 - 29225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability